KemPharm, Inc. Reports First Quarter 2017 Results
May 10, 2017 20:07 pm UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Clinical Development Regulatory Highlights:Reported Positive Data from Proof-of-Concept Phase 1 Intranasal Pharmacokinetic...
Points International to Present at Upcoming Investor Conferences
May 10, 2017 20:07 pm UTC| Business
TORONTO, May 10, 2017 -- Points (TSX:PTS) (Nasdaq:PCOM), the global leader in powering loyalty commerce, today announced that the Company will present at the following upcoming investor conferences: Three Part...
Points International to Present at Upcoming Investor Conferences
May 10, 2017 20:07 pm UTC| Business
TORONTO, May 10, 2017 -- Points (TSX:PTS) (Nasdaq:PCOM), the global leader in powering loyalty commerce, today announced that the Company will present at the following upcoming investor conferences: Three Part...
Otonomy to Present at the Bank of America Merrill Lynch Health Care Conference
May 10, 2017 20:07 pm UTC| Business
SAN DIEGO, May 10, 2017 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that...
Otonomy to Present at the Bank of America Merrill Lynch Health Care Conference
May 10, 2017 20:07 pm UTC| Business
SAN DIEGO, May 10, 2017 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that...
Otonomy to Present at the Bank of America Merrill Lynch Health Care Conference
May 10, 2017 20:07 pm UTC| Business
SAN DIEGO, May 10, 2017 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that...
Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update
May 10, 2017 20:07 pm UTC| Business
GERMANTOWN, Md., May 10, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, reported its financial results for the quarter ended March...